CoChat

Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA Damage

Open access
Johnson, Neil, Cai, Dongpo, Kennedy, Richard D., Pathania, Shailja, Arora, Mansi, Li, Yu-Chen, D'Andrea, Alan D., Parvin, Jeffrey D., Shapiro, Geoffrey I. · 2009 · Molecular Cell
Cited by 138

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

SUMMARY Cdk2 and cdk1 are individually dispensable for cell cycle progression in cancer cell lines because they are able to compensate for one another. However, shRNA-mediated depletion of cdk1 alone or small molecule cdk1 inhibition abrogated S phase cell cycle arrest and the phosphorylation of a subset of ATR/ATM targets after DNA damage. Loss of DNA damage-induced checkpoint control was caused by a reduction in formation of BRCA1-containing foci. Mutation of BRCA1 at S1497 and S1189/S1191 resulted in loss of cdk1-mediated phosphorylation and also compromised formation of BRCA1-containing foci. Abrogation of checkpoint control after cdk1 depletion or inhibition in non-small cell lung cancer cells sensitized them to DNA damaging agents. Conversely, reduced cdk1 activity caused more potent G2/M arrest in non-transformed cells, and antagonized the response to subsequent DNA damage. Cdk1 inhibition may therefore selectively sensitize BRCA1 proficient cancer cells to DNA damaging treatments by disrupting BRCA1 function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2009.06.036

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Johnson, N., Cai, D., Kennedy, R. D., Pathania, S., Arora, M., Li, Y.-C., D'Andrea, A. D., Parvin, J. D., & Shapiro, G. I.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2009-08
Volume
35
Issue
3
Pages
327-339
ISSN
1097-2765 (ISSN-L)
OpenAlex
W2051075276
Cited by
138
References
7
FWCI
2.88
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.